South Carolina 2025-2026 Regular Session

South Carolina House Bill H5667

Introduced
5/6/26  

Caption

A BILL TO AMEND THE SOUTH CAROLINA CODE OF LAWS BY ENACTING THE "APOTHECARY RETAILER ACT" BY ADDING CHAPTER 140 TO TITLE 44 SO AS TO REGULATE THE SALE OF CERTAIN HEMP-DERIVED CANNABINOID PRODUCTS, SMOKING CESSATION PRODUCTS, AND WELLNESS PRODUCTS THROUGH THE USE OF LICENSED APOTHECARY RETAILERS; TO ESTABLISH AGE AND OTHER RESTRICTIONS APPLICABLE TO THE SALE OF COVERED PRODUCTS; TO EXEMPT APOTHECARY RETAILERS AND COVERED PRODUCTS FROM REGULATION PURSUANT TO TITLE 61; TO REQUIRE THE DEPARTMENT OF REVENUE TO ESTABLISH AND ISSUE APOTHECARY RETAILER LICENSES, TO PROMULGATE REGULATIONS, AND TO ENFORCE THE PROVISIONS OF THE CHAPTER; AND FOR OTHER PURPOSES.

Summary

H5667, the “Apothecary Retailer Act,” would create a new retail license category in South Carolina for stores selling certain hemp-derived cannabinoid products, smoking cessation products, and wellness-oriented products in a controlled, age-restricted setting. The bill defines “covered products” broadly to include items such as low-dose hemp-derived THC beverages, CBD products, nicotine replacement therapies, vapor products, herbal products, nonalcoholic functional beverages, and dietary supplements. The bill directs the Department of Revenue to create and administer an apothecary retailer license, set at an annual fee of $300 per location, and to issue regulations and enforce the chapter. It also sets product and retail rules, including a minimum purchase age of 21, mandatory age verification, behind-the-counter storage, a ban on vending machine sales, limits on hemp-derived products to no more than 10 milligrams of THC per serving, and prohibitions on synthetic cannabinoids, child-appealing marketing, and on-premises consumption unless otherwise authorized by law.

Impact

The bill would amend Title 44 of the South Carolina Code by adding a new Chapter 140 governing apothecary retailers and would carve these businesses and products out of regulation under Title 61, which generally governs alcohol-related licensing and control. It would give the Department of Revenue authority to license retailers, prioritize certain applicants, promulgate rules, and impose civil penalties, license suspension, or revocation for violations. The measure would affect retailers, hemp-product sellers, nicotine and cessation-product vendors, and businesses offering wellness products by creating a new compliance framework and a separate retail channel for these goods.

Sentiment

The bill’s stated purpose suggests generally favorable sentiment toward creating a regulated marketplace for alternative wellness and cessation products, with emphasis on consumer safety, age restriction, and support for small and veteran-owned businesses. Because there are no committee transcripts or recorded votes provided, there is no direct evidence of opposition or support from legislators in the available record. The bill text itself frames the proposal as a public-health and business-development measure rather than a punitive restriction.

Contention

The main points of potential contention are likely to be the scope of products covered, especially hemp-derived cannabinoid products and low-dose THC beverages, and the decision to exempt these products from Title 61 oversight. Some may question whether the new category could blur lines between wellness products, nicotine products, and intoxicating hemp products, or whether the 21-and-over standard and product limits are sufficient. Others may support the bill’s tighter controls, arguing that a dedicated license and age-restricted retail model better protects consumers and minors while giving legitimate businesses a clearer regulatory path.

Companion Bills

No companion bills found.

Previously Filed As

SC A1015

Establishes requirements for certain tobacco product retailers to stock and sell nicotine replacement therapy products.

SC H3601

Hemp Derived Canabis

SC H4030

South Carolina Kratom Consumer Protection Act

SC H3935

Hemp-Derived Consumables

SC H5202

Nitrous Oxide

SC S10366

Requires certain retailers stock nicotine replacement therapy products; establishes procedures in how nicotine replacement therapy products may be sold.

SC A11208

Requires certain retailers stock nicotine replacement therapy products; establishes procedures in how nicotine replacement therapy products may be sold.

SC H3096

Gene Therapy

SC SB1413

AN ACT to amend Tennessee Code Annotated, Title 39; Title 40; Title 43, Chapter 27; Title 53, Chapter 11; Title 57 and Title 67, relative to the regulation of hemp-derived cannabinoid products.

SC HB1376

AN ACT to amend Tennessee Code Annotated, Title 39; Title 40; Title 43, Chapter 27; Title 53, Chapter 11; Title 57 and Title 67, relative to the regulation of hemp-derived cannabinoid products.

Similar Bills

RI H5866

Increases the maximum fill for non-opioid, non-narcotic controlled substances found in schedule II, so that a sixty-day (60) supply may be dispensed at any one time.

RI S0795

Increases the maximum fill for non-opioid, non-narcotic controlled substances found in schedule II, so that a ninety-day (90) supply may be dispensed at any one time.

RI H8318

Prescriptions for testosterone not allowed to be transmitted or reported within the prescription drug monitoring database and removes from the records all existing information concerning prior testosterone prescriptions.

RI S2889

Prescriptions for testosterone not allowed to be transmitted or reported within the prescription drug monitoring database and removes from the records all existing information concerning prior testosterone prescriptions.

OH SB152

Allow wild animal rehab facility to get euthanasia drug permit

HI HB132

Relating To Expungement.

HI HB951

Relating To Prescription Drugs.

WI SB632

Naturopathic doctors. (FE)